Research Topics
| Gary NelsestuenSummaryAffiliation: University of Minnesota Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Top-down proteomic analysis by MALDI-TOF profiling: Concentration-independent biomarkersGary L Nelsestuen
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA
Proteomics Clin Appl 2:158-66. 2008..Diagnosis by longitudinal analysis of the same individual might increase sensitivity of protein biomarkers by 20-fold or more. Protein changes that exceed the range of values found among healthy individuals may be uncommon...
Plasma protein profiling: unique and stable features of individualsGary L Nelsestuen
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA
Proteomics 5:4012-24. 2005....
Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejectionGary L Nelsestuen
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA
Proteomics 5:1705-13. 2005..HNP levels did not correlate with episodes of acute rejection, cytomegalovirus or fungal infection. In conclusion, elevated HNP levels are associated with the onset of BOS and can predate the clinical onset of disease up to 15 months...
Views on methods for monitoring recombinant factor VIIa in inhibitor patientsNigel S Key
Department of Medicine, Divisionof Hematology, University of Minnesota, MN, USA
Semin Hematol 41:51-4. 2004..To date, however, no assay endpoint has been developed that can correlate accurately with clinical outcomes in a sufficiently large patient sample...
Analysis of chronic lung transplant rejection by MALDI-TOF profiles of bronchoalveolar lavage fluidYan Zhang
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, MN 55455, USA
Proteomics 6:1001-10. 2006..Overall, this study demonstrated the feasibility of this approach for the detection of disease biomarkers...
Studying multiple protein profiles over time to assess biomarker validityRaj S Kasthuri
University of Minnesota, Department of Medicine, MMC 480, 420 Delaware Street SE, Minneapolis, MN 55455, USA
Expert Rev Proteomics 3:455-64. 2006..The focus of this review is to illustrate the principle and value of serial protein profiling using a rapid protein extraction method...
Possible synergy between recombinant factor VIIa and prothrombin complex concentrate in hemophilia therapyNigel S Key
Department of Medicine, University of Minnesota, Minneapolis, USA
Thromb Haemost 88:60-5. 2002..Results with other patients supported this hypothesis. With further evaluation, a therapeutic approach combining sequential PCC and rFVIIa may prove useful for treatment of bleeding refractory to either agent used alone...
Mutagenesis of the gamma-carboxyglutamic acid domain of human factor VII to generate maximum enhancement of the membrane contact siteStephen B Harvey
Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis 55455, USA
J Biol Chem 278:8363-9. 2003..Overall, the results suggest features of membrane binding by vitamin K-dependent proteins and provide reagents that may prove useful for research and therapy...
Unusual benefits of macromolecular shielding by polyethylene glycol for reactions at the diffusional limit: the case of factor VIIai and tissue factorMatthew Stone
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, St. Paul, MN 55108, USA
Biochemistry 41:15820-5. 2002..Overall, properties of PEG-modified proteins can suggest features of the kinetic mechanism and may provide enhanced proteins for anticoagulation therapy...
Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factorMatthew D Stone
Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, 6 155 Jackson Hall, 321 Church Street SE, Minneapolis, Minnesota 55455, USA
Biochemistry 44:6321-30. 2005..These results suggest novel actions of fVIIai that distinguish it from most of the anticoagulants that block later steps of the coagulation cascade...
Response of factor VIII and IX-deficient blood to wild type and high membrane affinity mutant factor VIIa in an in vitro whole blood clotting assay: possible correlation to clinical outcomeNicole Henderson
Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, St Paul 55108, USA
Thromb Haemost 88:98-103. 2002..The results may justify larger studies to determine the utility of this assay for evaluation of patient responsiveness and to set factor VIIa therapy levels...
Research Grants
- QUADRUPOLE TIME OF FLIGHT MASS SPECTROMETERGary Nelsestuen; Fiscal Year: 2001..An accessory nanospray HPLC system for application of small samples is also requested. The instrumentation that is requested is also critical for the emerging area of non-covalent macromolecular complexes. ..
- ENHANCED VITAMIN K DEPENDENT PROTEINSGary Nelsestuen; Fiscal Year: 2002..It will increase knowledge of the role that membranes play in enzymatic events of coagulation and in biological systems. It may ultimately provide new and/or improved materials for biomedical applications. ..
